This product is currently not available for purchase.


Life Cycle Assessment in Policy Context. Edition No. 1

  • ID: 1916205
  • May 2010
  • 340 Pages
  • VDM Publishing House
1 of 3

Thailand is one of the largest rice producing nations in the world. Rice husk is a co-product of rice products generated in the rice milling process. The husk has traditionally been used as an energy source in the rice mills. More recently, the Thai government has promoted the use of biomass to substitute for fossil fuel. Therefore, rice husk, which is one of the main sources of biomass in Thailand, has already been used on a commercial scale. However, the environmental aspect of these rice husk applications has not yet been widely investigated. This work compares the environmental performances of different rice husk uses. The major current and potential rice husk uses examined in this work are those in electricity generation, in cement manufacture and in cellulosic ethanol production. Life Cycle Assessment (LCA) approach was used to assess the environmental impacts of the selected rice husk uses. This book provides discussion on how LCA results are reviewed in policy context. While the study focuses on Thailand, the LCA approach and the broad results will be useful in other situations, and of interest to policy makers and other stakeholders in government, industry and academia.

Note: Product cover images may vary from those shown
2 of 3

Jittima Prasara-A has formal qualifications in engineering and a PhD from RMIT University, Australia. Before her current position as a lecturer in the Faculty of Environment and Resource Studies, Mahasarakham University, Thailand, Jittima was employed as a research assistant with Life Cycle Assessment Program, Centre for Design, RMIT University.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


If you have a more general question about our products please try our


Our Clients

  • AB Sciex
  • Eli Lilly and Company
  • B. Braun Melsungen AG
  • Astellas Pharma, Inc.
  • Hologic Corporation
  • Merck & Co., Inc.